Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Alore

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Rheumatology|February 6, 2021
Correction to: How do patients define Raynaud's phenomenon? Differences between primary and secondary diseaseSusan L Murphy, Alain Lescoat, Mary Alore, et al.
Clinical Rheumatology|January 24, 2021
How do patients define Raynaud's phenomenon? Differences between primary and secondary diseaseSusan L Murphy, Alain Lescoat, Mary Alore, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
Peer mentoring program through a digital platform for people with systemic sclerosis: A feasibility studyYen T Chen, Nirali Shah, Mary Alore, et al.
Rheumatology Advances in Practice|April 15, 2024
Impact of a resilience-building energy management intervention for people with systemic sclerosis: a mixed methods studyYen T Chen, Alexandra E Harper, Tiffany Phanhdone, et al.
Arthritis Care & Research|October 17, 2023
Effects of a Resilience-Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled TrialSusan L Murphy, Yen T Chen, Mary Alore, et al.
Arthritis Care & Research|May 10, 2018
Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic SclerosisDinesh Khanna, Jennifer Serrano, Veronica J Berrocal, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Rheumatology|February 6, 2021
Correction to: How do patients define Raynaud's phenomenon? Differences between primary and secondary diseaseSusan L Murphy, Alain Lescoat, Mary Alore, et al.
Clinical Rheumatology|January 24, 2021
How do patients define Raynaud's phenomenon? Differences between primary and secondary diseaseSusan L Murphy, Alain Lescoat, Mary Alore, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
Peer mentoring program through a digital platform for people with systemic sclerosis: A feasibility studyYen T Chen, Nirali Shah, Mary Alore, et al.
Rheumatology Advances in Practice|April 15, 2024
Impact of a resilience-building energy management intervention for people with systemic sclerosis: a mixed methods studyYen T Chen, Alexandra E Harper, Tiffany Phanhdone, et al.
Arthritis Care & Research|October 17, 2023
Effects of a Resilience-Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled TrialSusan L Murphy, Yen T Chen, Mary Alore, et al.
Arthritis Care & Research|May 10, 2018
Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic SclerosisDinesh Khanna, Jennifer Serrano, Veronica J Berrocal, et al.
Pageof 1